Bcr-Abl-mediated protection from apoptosis downstream of mitochondrial cytochrome c release.
about
Rsk-mediated phosphorylation and 14-3-3ɛ binding of Apaf-1 suppresses cytochrome c-induced apoptosisMisfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer.Interspecies Variation in the Functional Consequences of Mutation of Cytochrome cSynergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia.FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.Normal ABL1 is a tumor suppressor and therapeutic target in human and mouse leukemias expressing oncogenic ABL1 kinases.Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.Caspase-independent cell death: leaving the set without the final cut.Metabolic regulation of oocyte cell death through the CaMKII-mediated phosphorylation of caspase-2.Molecules that modulate Apaf-1 activity.Multidrug resistance in chronic myeloid leukaemia: how much can we learn from MDR-CML cell lines?Cardiotoxicity associated with targeted cancer therapies.Structure-activity relationships of glucosamine-derived glycerolipids: the role of the anomeric linkage, the cationic charge and the glycero moiety on the antitumor activity.Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias.Minimization of apoptosis-like changes in cryopreserved buffalo bull sperm by supplementing extender with Bcl-2 protein.Protein kinase A regulates caspase-9 activation by Apaf-1 downstream of cytochrome c.Inducing cell death in vitro in cancer cells by targeted delivery of cytochrome c via a transferrin conjugate.
P2860
Q24301885-F5C1F70D-9A54-4E5B-A631-4F65C8F943DFQ30374671-86C2C010-3202-4D65-B66A-8C7FDC9FB713Q33423736-40022F7A-2023-4289-95E6-2F3FB8FD6FEDQ33482818-8D8505B6-1228-4802-A015-4BBEEBA09DBBQ36334327-7F8DDB6B-999D-4909-9992-6666A1CF54CBQ36851400-821510DD-5779-4FCD-9182-2E33EB229D68Q37170788-1B980158-2E17-4AEC-B1B6-14B05BDE9A53Q37310195-03B6EA63-F89B-43A1-B264-1DAC11EA0DCFQ37459556-3E733C72-52C7-497F-B03B-6A11E2838634Q37680800-3A46ADE5-C6E2-4CE5-8DD6-35E74DEBE8F8Q38144200-2730F3F6-6108-4BA0-9D7F-74F54B6964A8Q38819670-4AB43F27-3B59-4AB2-BDD2-CFD32428AF59Q39209758-2C48BCB4-1912-40ED-9690-980B98872360Q39966770-C3396054-D47F-4FB2-B582-892EF620FFD5Q41818740-479E9EF4-9B6A-465B-8194-57BDFAA6C16FQ45259224-9ED0C4F5-5E64-4FD5-ADFC-CCF00567FD2CQ52719808-0CA90C90-F32C-4195-B521-55ED5267B55B
P2860
Bcr-Abl-mediated protection from apoptosis downstream of mitochondrial cytochrome c release.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bcr-Abl-mediated protection fr ...... hondrial cytochrome c release.
@en
Bcr-Abl-mediated protection fr ...... hondrial cytochrome c release.
@nl
type
label
Bcr-Abl-mediated protection fr ...... hondrial cytochrome c release.
@en
Bcr-Abl-mediated protection fr ...... hondrial cytochrome c release.
@nl
prefLabel
Bcr-Abl-mediated protection fr ...... hondrial cytochrome c release.
@en
Bcr-Abl-mediated protection fr ...... hondrial cytochrome c release.
@nl
P2093
P2860
P1476
Bcr-Abl-mediated protection fr ...... hondrial cytochrome c release.
@en
P2093
Jessica S Tashker
Malia B Potts
Mohanish Deshmukh
Paula B Deming
Sally Kornbluth
Zachary T Schafer
P2860
P304
10289-10299
P356
10.1128/MCB.24.23.10289-10299.2004
P407
P577
2004-12-01T00:00:00Z